Frank Pallone actually said...

"the purpose of the breakthrough therapy designation was to, as you say, Mr. Pallone, too, advance and give the flexibility for FDA to respond to the current state of science"

"If we are going to have a comprehensive discussion about how to promote innovation and medical advancements, we can't simply focus on the FDA."

"I look forward to working with my colleagues in a bipartisan way to ensure that promising new medicines get to patients in a timely manner, and they are safe and effective."

"We all agree that the Federal Government and Congress can play a role to help accelerate the discovery, development and delivery of promising new treatments to patients."